Exploring The Emerging Trends And Innovations In Sepsis Diagnostics Market 2023


(MENAFN- EIN Presswire)

sepsis diagnostics market

Rise in government funding for sepsis-related research activities and increase in the prevalence of infectious diseases drive the growth of the Market

PUNE, MAHARASHTRA, INDIA, February 9, 2023 /einpresswire.com / -- Sepsis diagnostics refer to the tests and procedures used to diagnose sepsis, a potentially life-threatening condition that occurs when an infection spreads throughout the body and triggers a severe immune response. The goal of sepsis diagnostics is to identify the presence of sepsis as early as possible and initiate prompt treatment to prevent severe complications and improve outcomes.

Allied Market Research has published a study report with the title sepsis diagnostics market size was Valued at USD 569.49 million in 2020, and is Projected to Garner USD 1.2 billion by 2030, registering a CAGR of 7.8% from 2021 to 2030.

Rise in government funding for sepsis-related research activities and increase in the prevalence of infectious diseases drive the growth of the global sepsis diagnostic market. On the other hand, high costs associated with automated diagnostics devices impede the growth to some extent. However, developments in rapid diagnosis/point-of-care) techniques for early sepsis diagnostics are expected to create lucrative opportunities in the industry.

Get Sample PDF Report with Graphs and Figures Here:

Top Key Players of Sepsis Diagnostics Market are BioMerieux SA, Thermo Fisher Scientific Inc., Abbott Laboratories, Inc., Becton, Dickinson and Company, Bruker Corporation, Beckman Coulter, Inc., T2 Biosystems, Inc, Nanosphere, Inc., Hoffmann-LA Roche Ltd, Danaher Corporation

Sepsis Diagnostics Market Segmentation: -

By method, the conventional diagnostics segment held the major share in 2020, garnering nearly three-fourths of the global sepsis diagnostic market, due to the cost-effectiveness of conventional diagnostics methods as compared to automated diagnostic practices. The automated diagnostics segment, on the other hand, is projected to cite the fastest CAGR of 8.3% throughout the forecast period.

By product, the blood culture media segment contributed to the lion's share in 2020, holding nearly two-fifths of the global sepsis diagnostic market. Increase in the number of sepsis case, rise in geriatric population, high incidence of bloodstream infection, and growth in the demand for rapid diagnostic techniques fuel the segment growth. However, the instruments segment is projected to manifest the fastest CAGR of 8.7% from 2021 to 2030.

By region, North America dominated in 2020, garnering nearly half of the global sepsis diagnostic market, due to the presence of highly advanced healthcare system, high adoption of innovative sepsis diagnostics technology, and technological development in the field of sepsis diagnostic. The market across Asia-Pacific, simultaneously, is expected to cite the fastest CAGR of 8.9% throughout the forecast period. Growing demand for sepsis diagnostics solutions in countries such as China and India fuels the market growth.

Purchase the Report:

Our Market Research Solution Provides You Answer to Below Mentioned Question:

Which are the driving factors responsible for the growth of market?
Which are the roadblock factors of this market?
What are the new opportunities, by which market will grow in coming years?
What are the trends of this market?
Which are main factors responsible for new product launch?
How big is the global & regional market in terms of revenue, sales and production?
How far will the market grow in forecast period in terms of revenue, sales and production?
Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
Which region has more opportunities?

By Region Outlook

. North America
(U.S., Canada, Mexico)
. Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
. Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
. LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of“Market Research Reports” and“Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+ +1 503-894-6022
email us here
Visit us on social media:
facebook
twitter
linkedin

MENAFN09022023003118003196ID1105549878


EIN Presswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.